Dengue viruses are a leading cause of morbidity throughout the tropics and subtropics. Attempts to develop live attenuated dengue vaccines analogous to the yellow fever vaccine have been unsuccessful. In an effort to contribute to the development of a recombinant dengue vaccine, the investigators propose to investigate expression of the Den-3 envelope glycoprotein in the filamentous fungus Neurospora crassa.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI032272-01
Application #
3489554
Study Section
Special Emphasis Panel (SSS (B))
Project Start
1992-02-01
Project End
1992-09-30
Budget Start
1992-02-01
Budget End
1992-09-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Hawaii Biotech, Inc.
Department
Type
DUNS #
113226823
City
Aiea
State
HI
Country
United States
Zip Code
96701